We are live on ! Find out more
HBT

Hills Bank & Trust Portfolio holdings

AUM $2.07B
1-Year Est. Return 13.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+13.46%
3 Year Est. Return
+47.48%
5 Year Est. Return
+61.32%
10 Year Est. Return
+236.61%
AUM
$341M
AUM Growth
+$22.6M
Cap. Flow
+$2.52M
Cap. Flow %
0.74%
Top 10 Hldgs %
44.37%
Holding
136
New
8
Increased
30
Reduced
76
Closed
2

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.59M
2
USB icon
US Bancorp
USB
+$1.08M
3
GE icon
GE Aerospace
GE
+$442K
4
LNT icon
Alliant Energy
LNT
+$253K
5
CINF icon
Cincinnati Financial
CINF
+$226K

Sector Composition

Rank Sector Weight
1 Financials 10.93%
2 Healthcare 10.55%
3 Technology 9.51%
4 Industrials 7.42%
5 Consumer Discretionary 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
26
US Bancorp
USB
$98B
$3.69M 1.08%
68,905
-19,988
-22% -$1.08M
TMO icon
27
Thermo Fisher Scientific
TMO
$214B
$3.46M 1.01%
18,236
-282
-2% -$54K
XLE icon
28
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$3.35M 0.98%
92,634
-1,356
-1% -$46.7K
CVS icon
29
CVS Health
CVS
$134B
$3.2M 0.94%
44,182
-1,054
-2% -$76.6K
IAK icon
30
iShares US Insurance ETF
IAK
$510M
$3.12M 0.92%
46,897
-218
-0.5% -$14.4K
ZBH icon
31
Zimmer Biomet
ZBH
$18.2B
$2.57M 0.75%
21,918
-75
-0.3% -$8.48K
TROW icon
32
T. Rowe Price
TROW
$24.1B
$2.56M 0.75%
24,366
-59
-0.2% -$5.75K
DIS icon
33
Walt Disney
DIS
$167B
$2.48M 0.73%
23,050
+5
+0% +$515
C icon
34
Citigroup
C
$223B
$2.41M 0.71%
32,345
-110
-0.3% -$8.13K
KSS icon
35
Kohl's
KSS
$2.19B
$2.31M 0.68%
42,628
-699
-2% -$32.2K
ESRX
36
DELISTED
Express Scripts Holding Company
ESRX
$2.3M 0.67%
30,791
+1,028
+3% +$65.7K
DCI icon
37
Donaldson
DCI
$10.9B
$2.19M 0.64%
44,650
-302
-0.7% -$14.4K
SBUX icon
38
Starbucks
SBUX
$120B
$2.16M 0.63%
37,562
-56
-0.1% -$3.17K
IHF icon
39
iShares US Healthcare Providers ETF
IHF
$1.21B
$2.1M 0.62%
67,045
-450
-0.7% -$13.5K
EOG icon
40
EOG Resources
EOG
$78.9B
$2.09M 0.61%
19,387
-292
-1% -$29.4K
XRAY icon
41
Dentsply Sirona
XRAY
$2.7B
$2.02M 0.59%
30,755
-256
-0.8% -$16.3K
HTLD icon
42
Heartland Express
HTLD
$958M
$1.97M 0.58%
84,540
CVX icon
43
Chevron
CVX
$393B
$1.93M 0.57%
15,420
-80
-0.5% -$9.49K
BRK.A icon
44
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.79M 0.52%
6
TFCFA
45
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.77M 0.52%
51,221
-995
-2% -$29.7K
PFE icon
46
Pfizer
PFE
$143B
$1.75M 0.51%
50,775
+28,817
+131% +$983K
QCOM icon
47
Qualcomm
QCOM
$156B
$1.73M 0.51%
26,950
+222
+0.8% +$13.5K
SLB icon
48
SLB Ltd
SLB
$73.7B
$1.68M 0.49%
24,991
-642
-3% -$41.6K
SCHW
49
Charles Schwab
SCHW
$183B
$1.67M 0.49%
32,468
-144
-0.4% -$6.76K
BFH icon
50
Bread Financial
BFH
$4.33B
$1.65M 0.48%
8,168
+119
+1% +$22.1K

Similar funds

Hills Bank & Trust's Q4 2017 Portfolio in Review

As of Q4 2017, Hills Bank & Trust held 136 positions worth $341M, up 7.1% from $319M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Hills Bank & Trust's Q4 2017 filing shows 8 new, 30 increased, 76 reduced and 2 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 135,155 shares worth $4.5M. The largest sale was Allergan plc, an estimated $1.59M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Technology.

  • Hills Bank & Trust's largest Q4 2017 buy was FlexShares Global Upstream Natural Resources Index Fund: 135,155 shares worth $4.5M.
  • Hills Bank & Trust added most to Pfizer in Q4 2017, an estimated $983K increase.
  • Hills Bank & Trust's biggest Q4 2017 reduction was US Bancorp, cutting an estimated $1.08M.
  • Hills Bank & Trust fully exited Allergan plc in Q4 2017, selling an estimated $1.59M.
  • Hills Bank & Trust's ten largest holdings make up 44% of its $341M portfolio in Q4 2017.
  • Hills Bank & Trust opened 8 new positions and closed 2 in Q4 2017.
  • Hills Bank & Trust's portfolio value rose 7.1% quarter-over-quarter to $341M.

Based on Hills Bank & Trust's 13F filing for Q4 2017, filed 16 Jan 2018.